Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods

HIV Medicine

Volumn 9, Issue 4, 2008, Pages 203-207

  Saindou, M ^a,b   Chidiac, C ^c,d   Miailhes, P ^c,e,f   Voirin, N ^a,b,g   Baratin, D ^g   Amiri, M ^c,e,f   Livrozet, J M ^g   Touraine, J L ^g   Trepo, C ^c,e,f   Peyramond, D ^d   Vanhems, Philippe ^a,b,c,g  

^a UNIVERSITÉ DE LYON   (France)

^b LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e INSERM   (France)

^f HÔTEL DIEU   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Acquired immune deficiency syndrome; Community acquired pneumococcal pneumonia; Highly active antiretroviral therapy; Human immunodeficiency virus; Lyon

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; TREND STUDY;

EID: 41549167773     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00546.x     Document Type: Article

References (10)

1. Mocroft A, Ledergerber B, Katlama C et al. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet 2003; 362: 22-29.
2. Heffeman RT, Barrett NL, Gallagher KM et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in the era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005; 191: 2038-2045.
3. Navin TR, Rimland D, Lennox JL et al. Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus. J Infect Dis 2000; 181: 158-164.
4. Le Moing V, Rabaud C, Journot V et al. Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen. HIV Med 2006; 7: 261-267.
5. Rimland D, Navin TR, Lennox JL et al. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002; 16: 85-95.
6. Tassie J-M, Grabar S, Lancar R, Deloumeaux J, Bentata M, Costagliola D. Time to AIDS 1992 to 1999 in HIV-1-infected subjects with known date of infection. J AIDS 2002; 30: 81-87.
7. Gayet-Ageron A, Baratin D, Marceillac E et al. The AIDS epidemic in Lyon: Patient characteristics and defining illnesses between 1985 and 2000. HIV Med 2004; 5: 163-170.
8. Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000; 162: 64-67.
9. Feikin DR, Feldman C, Schuchat A, Janoff EN. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004; 4: 445-455.
10. Miller V, Staszewski S, Sabin C et al. CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load. J Infect Dis 1999; 180: 530-533.